Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

The document concludes that understanding the sebaceous gland's development and function is key to addressing related skin diseases and aging effects.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Finasteride may cause slight depression and anxiety.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Micrografts improve hair density and thickness without side effects.

Melatonin solution helps treat hair loss in men and women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.